Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

L-Gulono-1,4-lactone

Product Specifications

CAS Number

1128-23-0

Synonyms

L-Gulonic acid, γ-lactone; Gulonic acid, γ-lactone, L- (8CI); Dihydroascorbic acid; L-Gulono-1,4-lactone; L-Gulono-γ-lactone; L-Gulonolactone; Reduced ascorbate; Reduced ascorbic acid; γ-Gulonolactone

Hazard Statement

No Data Available

Purity

>95% (HPLC)

Smiles

OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O

Molecular Formula

C6 H10 O6

Molecular Weight

178.14

InChI

InChI=1S/C6H10O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-5,7-10H,1H2/t2-,3+,4-,5+/m0/s1

Additionnal Information

IUPAC name: (3S,4R,5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one

Shipping Conditions

Room Temperature

Storage Conditions

+4°C

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Angiostatin Kringles 1-3, Recombinant, Human
MBS638242-01 0.02 mg

Angiostatin Kringles 1-3, Recombinant, Human

Ask
View Details
Angiostatin Kringles 1-3, Recombinant, Human
MBS638242-02 5x 0.02 mg

Angiostatin Kringles 1-3, Recombinant, Human

Ask
View Details
FLT4 (Fms-Related Tyrosine Kinase 4, FLT41, LMPH1A, PCL, VEGFR3) (MaxLight 550)
MBS6216904-01 0.1 mL

FLT4 (Fms-Related Tyrosine Kinase 4, FLT41, LMPH1A, PCL, VEGFR3) (MaxLight 550)

Ask
View Details
FLT4 (Fms-Related Tyrosine Kinase 4, FLT41, LMPH1A, PCL, VEGFR3) (MaxLight 550)
MBS6216904-02 5x 0.1 mL

FLT4 (Fms-Related Tyrosine Kinase 4, FLT41, LMPH1A, PCL, VEGFR3) (MaxLight 550)

Ask
View Details
Lentiviral human CAMK2A sgRNA gene knockout kit - Lentiviral human CAMK2A sgRNA gene knockout kit (25)
GTR15390669 1 Vial

Lentiviral human CAMK2A sgRNA gene knockout kit - Lentiviral human CAMK2A sgRNA gene knockout kit (25)

Ask
View Details
HMGB1 (Sulfoglucuronyl Carbohydrate Binding Protein, Amphoterin, SBP-1, High Mobility Group Box-1)
353419 100 µg

HMGB1 (Sulfoglucuronyl Carbohydrate Binding Protein, Amphoterin, SBP-1, High Mobility Group Box-1)

Ask
View Details